IASO Biotherapeutics’ World’s First Fully Human CD19/CD22 Dual-Targeted CAR-T Drug Receives Two IND Clearances, Enters Clinical Trials
NMPA’s Clearance of CT120 Marks Major Milestone in Treatment for B-Cell Malignancies PLEASANTON, Calif. &…
NMPA’s Clearance of CT120 Marks Major Milestone in Treatment for B-Cell Malignancies PLEASANTON, Calif. &…
Leading Data and Analytics Provider for Energy and Commodities Markets Will Provide New Pillars of…
Arcturus will receive $40 million upfront payment and potential royalties based on vaccines produced SAN…
Experienced pharmaceutical research and development strategist brings deep expertise in advancing innovative cancer medicines SHANGHAI…
BELMONT, N.C.--(BUSINESS WIRE)--Piedmont Lithium Inc. (Nasdaq: PLL) (ASX: PLL) (“Piedmont” or the “Company”) is pleased…
Headquartered in Alabama, Potter will lead the Company’s efforts to construct its first-of-its-kind graphite processing…
Consolidated Summary Report [under Japanese GAAP] for the three months ended June 30, 2021 TOKYO--(BUSINESS…
Q1 2021 Adjusted Net Sales reached an all-time high of $507 million and grew 39%…
- New Joint Venture Partner, JCP Capital, Adds Financial Strength for Continued Operation of Transphorm’s…
MIAMI BEACH, Fla.--(BUSINESS WIRE)--RMG Acquisition Corporation (NASDAQ: RMGB) (“RMG II”), a publicly-traded special purpose acquisition…